IP Library Patent Application 14416669
Patent Application
App. No. 14/416,669

CHONDROITIN COMPLEXES FOR TRANSCUTANEOUS ABSORPTION

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
14/416,669
Abstract

The present invention relates to the use of chondroitin as a transdermal carrier and slow-release system for active ingredients in pharmaceutical and cosmeceutical compositions.

Claims (11)

1 . Pharmaceutical and cosmeceutical compositions containing non-covalent complexes between non-sulphated chondroitin having molecular weight between 5 and 100 kDa determined by size-exclusion chromatography and active ingredients.

2 . Compositions according to claim 1 for the topical, nasal, rectal and vaginal administration.

3 . (canceled)

4 . Compositions according to claim 1 in the form of solutions, emulsions, gel, creams, sprays, suppositories, eyedrops, masks, patches, dressings and plasters.

5 . Non-covalent complexes of non-sulphated chondroitin having molecular weight between 5 and 100 kDa determined by size-exclusion chromatography and active ingredients.

6 . Non-covalent complexes according to claim 5 , wherein the active ingredient is a non-steroidal or steroidal anti-inflammatory, an antitumoral, an antiviral, an antimicrobial, a diuretic, a contraceptive, an analgesic, a bronchodilator, a monoclonal antibody, an immunosuppressant, a vasoconstrictor or a vasodilator, an antioxidant, a soothing, moisturising or draining agent, a biostimulant, a radical scavenger, a wrinkle treatment agent, a hair growth compound or a bioactive peptide, either used individually or in combinations thereof.

7 . (canceled)

8 . A method of transdermal and trans-mucosa delivery of a medicament comprising an active ingredient and non-sulphate chondroitin having molecular weight between 5 and 100 kDa determined by size-exclusion chromatography, said method comprising:

applying said medicament on skin or mucosa of a subject in need thereof; and

obtaining said transdermal and trans-mucosa delivery of said medicament in said patient in need.

9 . The method of claim 8 , wherein said active ingredient is selected from the group consisting essentially of steroidal and no-steroidal anti-inflammatory drugs, anti-tumorals, antivirals, antimicrobials, diuretics, contraceptives, analgesics, bronchodilators, monoclonal antibodies, immunosuppressants, vasoconstrictors or vasodilators, antioxidants, soothing agents, moisturizing agents, drainage agents, biostimulants, radical scavengers, wrinkle treatment agents, hair growth compounds, bioactive peptides and combination thereof.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 2, 2015
From: DE ROSA, MARIO; SCHIRALDI, CHIARA
To: ALTERGON S.A.
Reel/Frame 034862/0210 →